Disease-specific non–reducing end carbohydrate biomarkers for mucopolysaccharidoses

Mucopolysaccharidoses are caused by a deficiency in GAG processing and can often be treated if the dysfunctional enzyme can be identified. A chemical derivatization strategy in combination with biochemical logic now yields a series of biomarkers that can be used to distinguish these disorders.